Atlas Trials

Fengming Kong

3 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Fengming Kong

RecordFirmDate
A Phase I/ II Study of Fragmented Autoantigen Stimulated T-cell-immunotherapy Combined with Radiotherapy (FAST-CR) (NCT06756295)Fengming Kong2025-03-25
Tumor Control, Treatment Toxicity, Quality of Life and Bio-Imaging Repository Databank (TQ-BIRD) for Cancer Patients (NCT05061342)Fengming Kong2019-06-27

Track Fengming Kong automatically

Every clearance here is in the API, with alerts when new ones post.